Company
CEO
CEO
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
David Daly was last confirmed as Board Member at Neogenomics Inc (NEO) in a filing dated April 7, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
CEO
Source not stated
Start not stated–2023-04-07
Last confirmed by a filing; no departure on record
Recorded roles and call appearances connecting this person to public companies.
Company
CEO
No call appearances or filed executive changes recorded yet.